Holidaymakers urged to never ignore three symptoms 'after they return'
A health expert has delivered a chilling alert that tourists returning from abroad must never overlook three key warning signs that could signal serious disease. Pharmacologist Dan Baumgardt emphasised that jet-setters face the danger of bringing back hazardous illnesses - and should never simply brush off the red flags.
The senior academic from the School of Physiology, Pharmacology and Neuroscience at the University of Bristol highlighted three critical symptoms demanding immediate medical care - fever, stomach upset and yellowing of the skin. Penning his advice on the Conversation website, he declared: "International travel poses a risk of catching something more than a run-of-the-mill bug, so it's important to be vigilant for the tell-tale symptoms.
"Here are the main ones to look out for while away and when you return."
Fever
Mr Baumgardt explained: "Fever is a common symptom to note after international travel – especially to tropical or subtropical regions. While a feature of many different illnesses, it can be the first sign of an infection – sometimes a serious one."
He warned it might indicate Malaria which is a deadly condition triggered by parasites transmitted to people via bites from contaminated female Anopheles mosquitoes.
The disease poses a major worldwide health threat, affecting over 200 million individuals and causing hundreds of thousands of fatalities each year, reports the Daily Record.
Malaria remains especially widespread across tropical and subtropical areas globally. Early symptoms of the disease can mimic those of the flu, including headaches and muscle aches, but these can escalate to severe fever, sweating and shaking chills.
Other signs to look out for include jaundice (yellowing of the skin or eyes), swollen lymph nodes, rashes and abdominal pain – although these symptoms can vary greatly and can resemble many other conditions.
Mr Baumgardt warned: "Prompt medical attention is essential. Malaria is serious and can become life-threatening. It's also worth noting that symptoms may not appear until weeks or even months after returning home. In the UK, there are around 2,000 imported malaria cases each year.
"Travellers to at-risk areas are strongly advised to take preventative measures. This includes mosquito-bite avoidance as well as prescribed antimalarial medications, such as Malarone and doxycycline. Although these drugs aren't 100% effective, they significantly reduce the risk of infection."
There has also been an increase in Dengue fever, another disease transmitted by mosquitoes. Symptoms include high temperatures, severe headaches, body aches and rashes, which overlap with both malaria and other common viral infections.
Mr Baumgardt warned: "Most people recover with rest, fluids and paracetamol, but in some instances, dengue can become severe and requires emergency hospital treatment. A vaccine is also available – but is only recommended for people who have had dengue before, as it provides good protection in this group.
"Any fever after international travel should be taken seriously. Don't brush it off as something you've just picked up on the plane – please see a doctor. A simple test could lead to early diagnosis and might save your life."
Upset stomachs
Speaking about dodgy tummies, Mr Baumgardt revealed: "Few travel-related issues are as common – or as unwelcome – as diarrhoea. It's estimated that up to six in ten travellers will experience at least one episode during or shortly after their trip. For some, it's an unpleasant disruption mid-holiday; for others, symptoms emerge once they're back home.
"Traveller's diarrhoea is typically caused by eating food or drinking water containing certain microbes (bacteria, viruses, parasites) or their toxins. Identifying the more serious culprits early is essential – especially when symptoms go beyond mild discomfort."
He went on to stress that people should watch out for particular red flags - including large volumes of watery diarrhoea, blood present in stools or urgent toilet trips. He continued: "These may suggest a more serious infection, such as giardia, cholera or amoebic dysentery. These conditions are more common in regions with poor sanitation and are especially prevalent in parts of the tropics."
In certain instances, antibiotics and antiparasitic treatment may be required.
Jaundice
This ailment, which causes your skin or the whites of your eyes to turn yellow, can signal something severe like liver disease, so urgent medical attention is needed, according to NHS guidelines.
Whilst many people come back from holidays with a tan, it could also be an indication of jaundice.
Mr Baumgardt explained: "Several travel-related illnesses can cause jaundice. Malaria is one culprit as is the mosquito-borne yellow fever. But another common cause is hepatitis – inflammation of the liver.
"Viral hepatitis comes in several forms. Hepatitis A and E are spread via contaminated food or water – common in areas with poor sanitation. In contrast, hepatitis B and C are blood-borne, transmitted through intravenous drug use, contaminated medical equipment or unprotected sex."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
12 hours ago
- Telegraph
Why Brazil has built the world's largest mosquito factory
From the outside, the cavernous white building looks like any other factory. But step through the front door and the high pitched whine of insects signals that this is no ordinary assembly line: the new facility is producing mosquitoes. Billions of them. It sounds odd. Why would anyone breed more mosquitoes. Aren't there enough already buzzing around the globe, leaving in their wake a path of itchy bites and debilitating, sometimes fatal, fevers? Yet on Saturday, an team of scientists unveiled the world's largest mosquito factory in Curitiba, a city in southern Brazil. 'Nowhere in the world can produce the number of mosquitoes that will be produced here with this technology,' Alexandre Padilha, the country's health minister, said at the inauguration. '[The factory] represents an exercise in national sovereignty and innovation.' At its peak, the 5,000 square metre 'bio-factory' is set to churn out roughly 100 million mosquito eggs every week – more than five billion a year. These eggs, which carry a disease-blocking bacteria, will then be hatched in cities across the country, in the latest stage of an ambitious initiative to curb the spread of dengue. Colloquially known as 'breakbone fever', the mosquito-borne virus has wrought havoc across Latin America, with more than 13 million cases reported in the region last year – by far the worst epidemic on record. In Brazil alone, some 6.5 million people were infected, pushing the healthcare system to the brink, while 5,700 people died. 'You could see dengue everywhere – you'd go to the supermarket and there would be very few employees, because people were sick,' said Dr Luciano Moreira, a vector biologist and chief executive of Wolbito Brazil, one of the organisations behind the factory. 'So many friends and relatives were really ill… it was really a huge thing that affected everyone, rich and poor.' Now, after a year of construction, the factory in southern Brazil will start providing crucial reinforcements for Brazil's battle against the debilitating disease. That's because the Aedes aegypti mosquito eggs bred here carry a bacteria called Wolbachia, which blocks the mosquito's ability to transmit dengue. The Wolbachia bacteria is naturally found in a range of insects, though not the Aedes aegypti mosquito. When the insect is infected with the bacteria, it inhibits the dengue virus's ability to replicate inside it. In effect, the bacteria and the virus are competing for resources – and Wolbachia bacteria comes out on top. This has major ramifications for disease control, because it means the mosquito's bite no longer transmits the virus to people. The bacteria, which doesn't spread into humans, can also block Zika, yellow fever and chikungunya. 'We have seen that insecticides alone are not enough [to control dengue],' said Dr Moreira. 'You pay a lot, you have to damage the environment, and then the mosquitoes become resistant. So we really need to bring something else to the fight, and Wolbachia is one of these interventions. 'The advantage of Wolbachia is it's sustainable,' he added. 'It's biologically sound, it's not a chemical, and it doesn't interfere with the health of people or the environment or animals. So it holds a lot of promise.' It's not just Brazil that's in need of additional tools to fight dengue. In 1970, the virus had been detected in just seven countries; now roughly half the world's population are at risk of infection, with cases jumping to as many as 400 million a year. The increase – which is also occurring in Europe – has been driven by rising temperatures, rapid urbanisation and international travel. Experts hope that, alongside new vaccinations, Wolbachia could help turn the tide. There are two main ways the bacteria is deployed for disease control: either to suppress or replace mosquitoes. In Singapore, for instance, only male Wolbachia-infected mosquitoes are released. When they mate with wild, Wolbachia-free females, their eggs become infertile and do not hatch, causing the overall insect population to gradually get smaller over time. However, to be effective a constant stream of Wolbachia-carrying males have to be released. Brazil uses a different technique, reliant on both male and female Wolbachia-infected mosquitoes. When these bacteria-carrying insects mate, they pass the Wolbachia onto their offspring. The aim is that, after several generations, the majority of insects in any given area carry the bacteria, which then helps to suppress the spread of disease. 'In our case we want to have the replacement of the [mosquito] population, so that this becomes sustainable over time,' said Dr Moreira. 'We did a set of releases in 2014 and 2015. In those areas, Wolbachia is still in the mosquitoes. We don't need to do new releases again and again.' Since scientists at Monash University in Australia first identified the dengue-blocking capacity of Wolbachia some 15 years ago, multiple real-world studies have confirmed that this concept works – and it's safe. In 2020, a major randomised control trial in Indonesia found dengue cases dropped by 77 per cent in areas of Yogyakarta city where Wolbachia mosquitoes were released, while results in 2023 showed incidence fell by at least 94 per cent in three Colombian cities. But Dr Moreira warned the intervention is not an overnight fix. 'Wolbachia is a very powerful tool, especially when it is integrated with other measures,' he said. 'But it takes time for Wolbachia mosquitoes to establish. 'Politicians call in the middle of an epidemic and say they want us to come next month. We are clear and transparent that this won't help next month, it might take a year or two.' There are other limitations too, said Professor Eng Eong Ooi, a researcher at Duke-NUS Medical School's Emerging Infectious Diseases programme in Singapore. 'I think Wolbachia has shown great success but not universally. The environment, particularly how warm the place is, affects how well Wolbachia works,' he said. Mosquitoes were first released in the Brazilian capital Rio de Janeiro in a pilot in 2014. Studies have since shown drops in dengue of 38 per cent to 90 per cent in different areas of the city. The innovation has now become a central plank of the country's dengue control strategy, with Wolbachia mosquitoes so far released in 11 sites across Brazil. Until now, scientists were breeding roughly 15 million Wolbachia-carrying mosquito eggs every week, at a facility within the Fiocruz health institute in Rio. The biofactory in Curitiba will turbocharge the availability of disease-blocking insects, with scientists aiming to breed some 100 million mosquito eggs a week. 'The way we reared mosquitoes in the facilities for instance at Fiocrux, was a simple way: in trays and with lots of labour and hand processes,' said Dr Moreira. 'With the creation of our big factory now, we are bringing new equipment. We have machines to hatch the eggs… and we feed mosquitoes with automated devices.' He added that the facility also has a highly-controlled environment, to optimise conditions for the eggs, larvae and mosquitoes. Temperatures range from 27C to 29C depending on the stage of the life cycle, with humidity at 70 to 80 per cent, while insects are fed sugar, fish food and horse blood (a replacement for biting live animals, including humans). But only a small proportion of the eggs actually hatch in the factory. The vast majority will be shipped by car, plane and boat across the vast country as eggs, before local health officials add water and rear the larvae. 'We dry the eggs, and they don't hatch until they [come] into contact with the water,' said Dr Moreira. 'We put the eggs in capsules, or we can ship in filter paper. They can be [stored] for two or three months, they will still survive.' He added that the government has earmarked 40 cities, each home to more than 100,000 people, where they would like these eggs to be sent. Six cities have already been selected, where the first Curitiba-bred mosquitoes will be released as early as August. 'It will be exciting to get to that moment,' said Dr Moreira, who was working in the lab in Australia in 2009, when scientists first identified Wolbachia's disease-blocking potential. 'It's been a long time coming, slowly going through the scientific evidence and expanding into a robust programme in Brazil,' he added. 'Wolbachia is only one element of the solution for dengue, but I think it will be a very significant one for the country.'
Daily Mail
a day ago
- Daily Mail
'Danger to life' warning as two deadly diseases caused by mosquitoes strike tourists in Europe
A health alert has been issued for tourists traveling to Europe this summer as two potentially fatal diseases have been detected. In Italy, health authorities have reported the first locally acquired cases of dengue and chikungunya, mosquito-borne viruses that are typically found in tropical regions such as South America and India. Both were considered primarily imported diseases, found in individuals who had contracted them abroad. However, the two new cases indicate that the viruses were caught within the country, according to the British Foreign Office-backed Travel Health Pro. Dengue fever cases have seen a significant rise globally, reaching a record high in 2024 with over 14 million reported cases, according to the European Centre for Disease Prevention and Control. In June of this year, Australian holidaymakers were issued a warning after The Cook Islands, a nation in the South Pacific, declared the most recent outbreak of the disease after 19 cases, including two active cases, were recorded. Case counts have also been increasing in Samoa, Tonga, French Polynesia, Fiji and Kiribati. In July, Italy reported the first locally acquired case of dengue for the year, specifically in the Emilia-Romagna region, while 82 imported cases of the virus were recorded in several regions. Italian health officials also reported the first locally acquired case of chikungunya for the year, again found in the Emilia-Romagna region. An additional 50 imported cases of the virus were recorded across a number of regions. Earlier this month, holidaymakers jetting off to France were warned they were at risk of contracting chikungunya after eight local cases were recorded. The chikungunya outbreak has occurred far earlier in the year than is typical, and this could indicate the mosquitoes that carry chikungunya are becoming increasingly at home in France thanks to climate change, the warning said. Though not fatal, chikungunya can cause a range of effects, which are primarily marked by a sudden onset of fever and severe joint pain, while other common symptoms include muscle pain, headache, nausea, fatigue, and rash. While the acute phase of the illness usually resolves within a week or two, the joint pain can persist for weeks, months, or even years in some individuals. Meanwhile, dengue fever can cause a range of effects, including mild flu-like symptoms such as headache, fever and joint pain. However, in some cases, infections can progress to severe dengue, which can cause potentially life-threatening complications such as internal bleeding and organ damage, and death. Holidaymakers are urged to contact a local health professional immediately if they suspect they have been bitten by a mosquito during their travels.
Daily Mail
2 days ago
- Daily Mail
'Danger to life' warning issued as two deadly diseases detected at popular holiday destination
A health alert has been issued for British tourists travelling to a popular European destination this summer as two potentially fatal diseases have been detected. In Italy, health authorities have reported the first locally acquired cases of both dengue and chikungunya, mosquito-borne viruses that are typically found in tropical regions like South America and India. Both were previously considered primarily imported diseases, found in individuals who had contracted them abroad. However, the two new cases indicate that the viruses were caught within the country, according to the Foreign Office-backed Travel Health Pro. Dengue fever cases have seen a significant rise globally, reaching a record high in 2024 with over 14 million reported cases, according to the European Centre for Disease Prevention and Control. In June of this year, Australian holidaymakers were issued a warning after The Cook Islands, a nation in the South Pacific, declared the most recent outbreak of the disease after 19 cases, including two active cases, were recorded. Case counts have also been increasing in Samoa, Tonga, French Polynesia, Fiji and Kiribati. In July, Italy reported the first locally acquired case of dengue for the year, specifically in the Emilia Romagna region, while 82 imported cases of the virus were recorded in several regions. Italian health officials also reported the first locally acquired case of Chikungunya for the year, again found in the Emilia-Romagna region. An additional 50 imported cases of the virus were recorded across a number of regions. Earlier this month, holidaymakers jetting off to France were warned they were at risk of contracting chikungunya after eight local cases were recorded. The chikungunya outbreak has occurred far earlier in the year than is typical, and this could indicate the mosquitoes that carry chikungunya are becoming increasingly at home in France thanks to climate change, the warning said. Though not fatal, chikungunya can cause a range of effects, which are primarily marked by a sudden onset of fever and severe joint pain, while other common symptoms include muscle pain, headache, nausea, fatigue, and rash. While the acute phase of the illness usually resolves within a week or two, the joint pain can persist for weeks, months, or even years in some individuals. Meanwhile, dengue fever can cause a range of effects, including mild flu-like symptoms such as headache, fever and joint pain. However, in some cases, infections can progress to severe dengue, which can cause potentially life-threatening complications such as internal bleeding and organ damage, and death. Holidaymakers are urged to contact a local health professional immediately if they suspect they have been bitten by a mosquito during their travels. It comes as Hawaii health officials are asking visitors to ensure they are vaccinated against whooping cough as cases reach an all-time high in the state. Earlier this week, the state's Department of Health reported 108 cases of the Victorian-era disease — dubbed the 100-day cough — a stark increase from last year's 84 total cases. According to data from the CDC, about 10,000 cases of the coughing malady and nearly a dozen deaths have already been reported across the country this year.
